• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULARR XIENCE SKYPOINT; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULARR XIENCE SKYPOINT; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 2101741
Patient Problems Hypersensitivity/Allergic reaction (1907); Myocardial Infarction (1969); Rash (2033); Obstruction/Occlusion (2422); Unspecified Respiratory Problem (4464); Swelling/ Edema (4577)
Event Date 03/10/2023
Event Type  Injury  
Event Description
On date above had major heart attack with stent placed.15 days later had another heart attack & another stent placed which was 90% blocked at the time of my first heart attack.(b)(6) 2023 they put me on brilinta.I got a rash that looked like sun poisoning almost immediately also swelling across my nose with lots of snot going down my throat & my throat closing/swelling up.Now here eight months later the "rash" is extreme & has overtaken my whole body almost.It just started out on one of my forearms.On (b)(6) 2023 doctors added norvasc to my medications & and that's when we noticed the rash became unbearable.It's still going on and not really healing up.But some doctors seen have acted very concerned and some have acted like it's no big deal.Reference report: mw5149000.Refer to add'l documents in i2k.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
ABBOTT VASCULARR
MDR Report Key18290776
MDR Text Key330272782
Report NumberMW5149001
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/07/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Lot Number2101741
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
2 STENTS; AMLODIPINE BESYLATE; ASPIRIN 81MG; ATORVASTATIN 80MG; BRILINTA; ISOSORBIDE MONONITRATE 30MG; LOSARTAN 100M; METOPROLOL SUCCINATE ER 50MG; NITRO0.4MG; NORVASC; PREDNISONE 50MG - 5MG TAPERING; TYLENOL.... MAYBE ONCE A MONTH
Patient Outcome(s) Life Threatening; Other;
Patient Age50 YR
Patient SexMale
Patient Weight98 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-